Ebola Vaccine Trials Could Start This Year

As Ebola cases rise in Congo and Uganda, vaccine developers are accelerating efforts to combat the rare Bundibugyo strain. IAVI CEO Mark Feinberg says a candidate vaccine could enter human trials by year-end. (Source: Bloomberg)

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.